Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Achilles

This page shows the latest Achilles news and features for those working in and with pharma, biotech and healthcare.

Latest news

  • Neoantigen player Achilles gets OK for first clinical trial Neoantigen player Achilles gets OK for first clinical trial

    Will test the candidate in advanced NSCLC patients. Achilles Therapeutics is now a clinical-stage biotech after getting regulatory approval to start a phase 1/2 trial of its lead lung ... Approval of our first [clinical trial application] represents an

  • Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3 Daiichi-Sankyo takes rival to Roche’s Kadcyla into phase 3

    Phase 1 data have revealed activity in HER2-positive breast, lung and gastric cancers, without dose-limiting toxicities that have been the Achilles’ heel of many ADC therapies to date.

  • Outside looking in Outside looking in

    We know that as an industry this has long been our Achilles heel as other, easier to measure elements of the sales and marketing mix steal the lion’s share of

  • Antibiotics: pharma's Cinderella story Antibiotics: pharma's Cinderella story

    Yet perhaps the industry's greatest triumph has an Achilles heel. The dawn of the commercial age.

  • Cleaning up pharma's supply chain Cleaning up pharma's supply chain

    And that presents a problem in itself. As highlighted by recent reports from KPMG, IBM and Achilles, across the globe major corporations demonstrate a worrying lack of knowledge about their supply ... director of pharmaceutical and healthcare at Achilles

More from news
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...

Latest intelligence

Virtual Patient Engagement Program: A Customer Story
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
Humancomms for humancare?
Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...

Quick links